<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
AUGUST 15, 2000
------------------------------------
Date of Report (Date of
earliest event reported)
CORIXA CORPORATION
--------------------------------------------------------------------------------
(EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER)
<TABLE>
<S> <C> <C>
DELAWARE 0-22891 91-1654387
----------------------------- --------------------------- ---------------------------
(State or Other Jurisdiction (Commission File No.) (IRS Employer
of Incorporation) Identification No.)
</TABLE>
1124 COLUMBIA STREET, SUITE 200, SEATTLE, WASHINGTON 98104
--------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(206) 754-5711
--------------------------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
NONE
--------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE> 2
ITEM 5. OTHER EVENTS
On August 15, 2000, Corixa Corporation announced that it had entered into
a multi-year development, commercialization and license agreement with Medicis
Pharmaceutical Corporation covering Corixa's psoriasis immunotherapeutic
product, PVAC treatment. Further details regarding this announcement are
contained in the Company's press release dated August 15, 2000, which is
attached to this report as exhibit 99.1.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
(c) Exhibits
99.1 Corixa Press Release Dated August 15, 2000
<PAGE> 3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CORIXA CORPORATION
Dated: August 25, 2000 By /s/ Michelle Burris
-------------------------------------
Name: Michelle Burris
Its: Vice President and Chief Financial
Officer
<PAGE> 4
EXHIBIT INDEX
<TABLE>
<CAPTION>
Exhibit Number Description
-------------- -----------
<S> <C>
99.1 Corixa Press Release Dated August 15, 2000
</TABLE>
